Nycomed, Others Say Apotex Infringes Nasal Spray Patents

Law360, New York (August 6, 2012, 12:29 PM EDT) -- The producers of nasal spray Omnaris on Thursday leveled patent infringement allegations against Apotex Inc. in Indiana federal court, accusing the Canadian generics company of seeking to market a competing version of the allergy treatment that would infringe numerous patents.

Nycomed GmbH, Teijin Pharma Ltd. and Sunovion Pharmaceuticals Inc., all of which play some role in the distribution of Omnaris, contend that Apotex's planned version of the allergy treatment violates three patents despite the generics maker's claims to the contrary.

The patents-in-suit are U.S. Patents Number...
To view the full article, register now.